Metakelfin

Metakelfin: Antimalarial drug and its features

Metakelfin is an antimalarial drug produced by the Italian pharmaceutical company Carlo Erba Farmitalia. It is widely used for the treatment and prevention of malaria. Metakelfin is presented in the form of tablets containing 525 mg of active ingredients - pyrimethamine and sulfalene.

Indications for use of Metakelfin include the treatment and prevention of malaria. Malaria is a dangerous infectious disease transmitted through the bite of mosquitoes, which carry the parasites that cause malaria. Metakelfin has proven effective in controlling the disease and is widely used in countries where malaria is a public health problem.

It is important to note that Metakelfin has a number of contraindications. Its use is not recommended in case of individual intolerance to the components of the drug, as well as during pregnancy, lesions of the hepatic parenchyma, blood dyscrasia, severe renal failure, in children in the first two weeks of life and in women in the last 2 weeks of pregnancy. Before you start taking Metakelfin, you should consult your doctor to evaluate the indications and contraindications.

Like any medicine, Metakelfin may cause side effects. Some of them include nausea, vomiting, cutaneous erythema and the occurrence of blood dyscrasia. If skin erythema occurs, you should immediately stop taking the medication. If renal function is impaired, a dose reduction may be required.

At the moment, there is no known data on the interaction of Metakelfin with other drugs. However, it is always recommended to consult a doctor or pharmacist regarding possible interactions with other drugs or food.

There is no information about an overdose of Metakelfin in the scientific literature. In case of accidental overdose, seek medical attention or contact your local chemical poison information center for advice.

When treating pregnant women and children, Metakelfin should be prescribed only under medical supervision. This is due to the need to carefully monitor the patient’s condition and the presence of possible side effects.

In conclusion, Metakelfin is an antimalarial drug produced by the Italian pharmaceutical company Carlo Erba Farmitalia. It is a tablet containing pyrimethamine and sulfalene. Used for the treatment and prevention of malaria. However, before using Metakelfin, it is necessary to take into account contraindications, such as individual intolerance to the components of the drug, pregnancy, lesions of the hepatic parenchyma, blood dyscrasia, severe renal failure, children in the first two weeks of life and women in the last 2 weeks of pregnancy.

Possible side effects with Metakelfin include nausea, vomiting, skin erythema and blood dyscrasia. If skin erythema appears, you should stop taking the drug, and if renal function is impaired, a dose reduction may be necessary. The interaction of Metakelfin with other drugs is currently not known, so it is always recommended to consult a doctor or pharmacist.

There is no information about an overdose of Metakelfin. In case of accidental overdose, seek immediate medical attention.

Finally, when treating pregnant women and children, Metakelfin should only be used under medical supervision. This is due to the need to carefully monitor the patient's condition and possible side effects.

Metakelfin is one of the antimalarials developed to combat malaria. It represents an important tool in the medical fight against this dangerous infectious disease. However, before using it, it is necessary to carefully evaluate the indications and contraindications, and also consult a medical specialist.